10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2011 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 21, 2012) | |||
(In Millions, except shares in Thousands) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
Net Sales | $ 38,851 | 35,167 | 30,765 |
Cost of products sold | 15,541 | 14,665 | 13,209 |
Research and development | 4,129 | 3,724 | 2,744 |
Acquired in process and collaborations research and development | 672 | 313 | 170 |
Selling, general and administrative | 12,757 | 10,376 | 8,406 |
Total Operating Cost and Expenses | 33,099 | 29,079 | 24,529 |
Operating Earnings | 5,752 | 6,088 | 6,236 |
Interest expense | 530 | 553 | 520 |
Interest (income) | (85) | (105) | (138) |
Net foreign exchange (gain) loss | (50) | (11) | 36 |
Other (income) expense, net | 159 | (62) | (1,375) |
Earnings Before Taxes | 5,199 | 5,713 | 7,194 |
Taxes on Earnings | 470 | 1,087 | 1,448 |
Net Earnings | 4,728 | 4,626 | 5,746 |
Basic Earnings Per Common Share (in dollars per share) | 3.03 | 2.98 | 3.71 |
Diluted Earnings Per Common Share (in dollars per share) | 3.01 | 2.96 | 3.69 |
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,557,643 | 1,546,400 | 1,546,983 |
Dilutive Common Stock Options and Awards (in shares) | 9,746 | 9,622 | 8,143 |
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards (in shares) | 1,567,389 | 1,556,022 | 1,555,126 |
Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 26,789 | 29,403 | 66,189 |
External Links | |
ABBOTT LABORATORIES (ABT) Fiscal Year 2011 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |